NCT00404781View on ClinicalTrials.gov

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Ischemic Heart DiseaseAcute Coronary Syndromes
Interventions
DRUG

cilostazol in addition to aspirin and clopidogrel

Trial Locations (1)

110016

Northern Hospital, Shenyang

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER

NCT00404781 - Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter